High risk group

Maybe high risk so need assessment by genetics

All families who are thought to be high risk should be assessed by the Genetics Department by letter or by consultation. The RVI combined family history clinic has a genetics presence so is included.

The recommended screening is annual examination by a breast surgeon from age 35 or 5 years younger than youngest affected family member until age 50. Annual mammography should not start before 35 and commencing age is dependent on age of affected relatives. The age when mammograms start should be 5 years younger than youngest affected family member with 35 as a cut-off below which mammography should not be offered as screening. From age 50 these women move into the National Breast Screening Programme. The only exception being those women who have a BRCA1 or BRCA2 mutation or are at 50% risk of carrying one. These women should continue to be followed up on an annual basis in the relevant breast clinic until age 65.

Moderate risk group

The recommended screening is annual mammography from 5 years younger than the youngest relative (but not below the age of 35) to age 50 and then entry into the National Breast Screening Programme.

Low Risk Group

Any women with a less marked family history than those described above. These women should be reassured regarding their low risk status.

 

Family History of Breast Cancer
"Relative" includes first degree relative and their first degree relatives (first degree relatives - mother, father, brother sister, child).  
A
relative with clearly bilateral breast cancer can be viewed as two relatives for simplicity. A male relative with breast cancer counts as a young female (< 40)
Expected breast cancer cases between 40-50yrs
Population risk for breast cancer age 40 to 50 is 1 in 100 (1%), risks expressed as 1:n meaning 1 in every ‘n’ women with a similar family history would be expected to get breast cancer.
Lifetime relative risk
Population lifetime risk (age 20-80) years is 1 in 11 (9%).
Risk group
Risk category: 
Low risk
<2 x population lifetime risk. 
Moderate 2
-3 x population lifetime risk. 
High 3 x lifetime population risk.
Early mammography
Early screening mammography should start not younger than 35 years of age in the moderate risk group, the risk of cancer and potential benefits of screening are most likely to be seen in the 40-50 year age group.
Specialist genetics clinic
to be assessed with a view to genetic mutation analysis and more formal risk estimation.
1 relative 1 relative < 40yrs Maximum 1:50 Maximum 1:8 Low No No
1 relative < 40yrs
female < 30 or male affected at any age
1:30 - 1:50 
maximum 1:25
1:12 - 1:6 maximum 1:6 Low/moderate Yes No
Ethnic origin may make mutation searching easier for example Ashkenazi Jewish ancestry might mean genetic tasting would be more helpful even with a less striking family history.
2 relatives 2 relatives 50-60 yrs 1:40 1:8 Low No No
2 relatives average age 40-49 1:25 1:6 - 1:4 Moderate Yes No
Ethnic origin may make mutation searching easier for example Ashkenazi Jewish ancestry might mean genetic tasting would be more helpful even with a less striking family history.
2 relatives average age 30-39 1:14 1:4 -1:3 High Yes Yes
3 relatives 3 relatives average age 50-60 1:15 1:4 Moderate Yes Yes
3 relatives average age 40-50 1:11 1:3 High Yes Yes
Breast and other cancers 1 or more relative with < breast cancer 50 years + ³ 1 relative with ovarian cancer at any age OR one relative with both Usually more than 1:25 Usually more than 1:6 Moderate/high Yes Yes
1 or more relative with breast cancer < 40 years plus relative with childhood malignancy     May be high Avoid mammograms pending genetics review Yes

NHS Executive interim advice to GPs on familial breast cancer


Source: Dr L. McLean, breast Screening and Assessment Centre, Newcastle, November 1999.